Work

Initial safety, tolerability pharmacodynamics, and pharmacokinetics of CI-1007 in patients with schizophrenia.

Year: 1998

Type: article

Study design: Clinical Trial

Source: PubMed

Authors: J J Sramek, M A Eldon, E Posvar, M R Feng, S S Jhee, J Hourani, A J Sedman, N R Cutler

Institutions: Pfizer (United States), Pfizer (United Kingdom)

Language: English

Topic: Schizophrenia research and treatment

Subfield: Psychiatry and Mental health

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2410753988

FWCI: 0.908

Cites:

Cited by: 13

Related to: 10